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The advent of next-generation sequencing has proven to be a key force in the identification of new genes
associated with intellectual disability. In this study, high-throughput sequencing of the coding regions of
the X-chromosome led to the identification of a missense variant in the HUWE1 gene. The same variant
has been reported before by Froyen et al. (2008). We compare the phenotypes and demonstrate that, in
the present family, the HUWE1 mutation segregates with the more severe ID phenotypes of two out of
three brothers. The third brother has a milder form of ID and does not carry the mutation.
 2013 Elsevier Masson SAS. All rights reserved.1. Introduction
In 1991, the FMR1 gene was discovered to be responsible for the
Fragile X syndrome, the most common form of X-linked intellectual
disability (XLID) [1,2]. Ever since, many other genes have been re-
ported as XLID genes [3e5]. A substantial number of such genes
have been found or confirmed by presence of copy number changes
on arrays targeting specifically the X-chromosome [6e9].
The advent of next-generation sequencing has proven to be
another key force in the identification of new ID genes.Whereas the
whole-exome sequencing approach seems to be most effective in
isolated cases of ID, chromosome X exome sequencing is an alter-
native strategy that can be used in families with suspicion of XLID
[10e12]. In this study, high-throughput sequencing of the coding
regions of the X-chromosome led us to the identification of a
missense variant in the HUWE1 gene.
Copy number variants as well as missense mutations of HUWE1
have previously been reported in individuals with XLID [13]. This
study deals with a comparison of the clinical features and further
reinforcement of HUWE1 as an XLID gene. Moreover, we argue that
careful assessment of phenotypic heterogeneity e even within a, University Hospitals Leuven,
2, 3000 Leuven, Belgium.
(K. Devriendt).
on SAS. All rights reserved.family e is an important step toward correct genotypeephenotype
correlations.
2. Methods
The study was reviewed and approved by the ethical committee
of the hospital, and informed consent was obtained from the par-
ticipants and/or their caretakers. All affected patients underwent
clinical examination. Genomic DNA was isolated from peripheral
blood according to standard procedure guidelines. FMR1 analysis
and array-CGH results were normal (1 Mb BAC-array in II:1 and II:2
and 180k Oxford Gene Technology Cytosure oligoarray in II:3; see
Fig. 1). Because the pedigree was consistent with an X-linked in-
heritance pattern, it was selected for X-exome sequencing.
For the index patient we used 3 mg genomic DNA for con-
structing a single-end Illumina sequencing library with the Illu-
mina Genomic DNA Single End Sample Prep kit, according to the
instructions of the manufacturer. X-chromosome exome enrich-
ment was performed for the sequencing library using the Agilent
SureSelect Human X Chromosome Kit, which contains 47,657 RNA
baits for 7591 exons of the human X chromosome. Single-end deep
sequencing was performed on the Illumina Genome Analyzer
GAIIx. Read-length was 101 nucleotides. Sequences were analyzed
with in-house-developed tools.
Sanger sequencing was performed for validation of the promising
variants and subsequent segregationanalyses. Primersweredesigned
Fig. 1. Pedigree of the family.
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was used for amplification of the region of interest [14]. PCR products
were sequenced on an ABI3130xl sequencer (Life Technologies).




The three male siblings in this family all presented with intel-
lectual disability (Fig. 1). However, the phenotype in the eldestFig. 2. Upper panel: frontal view of (a) II:1 at age 7 years (b) II:2 at age 4 and (c) 8brother (II:1) was less marked in comparison to the younger sib-
lings (II:2 and II:3). Parents were non-consanguineous. The father
had a lower educational background. The mother was normal, but
clearly much more cognitively limited than her parents, brother
and sister. She had hypertelorism and macrocephaly.
II:1 was 9 years and 7months old at the time of investigation. He
had relative macrocephaly (OFC: 53.5 cm (p90); height 133 cm
(p25) and weight 39 kg (p75e90)) and hypertelorism. His IQ was
73. His younger brother II:2 had a more marked developmental
delay. He started walking at the age of 34 months. At 4 years and 11
months his parameters were: height 105 cm (p10), weight 20.1 kg
(p75) and OFC 53.4 cm (p90e97). He had hypertelorism, down-
slanting palpebral fissures, deep-set eyes and tapering fingers (see
Fig. 2). There was rest edema on both hands and feet. MRI of the
brainwas normal. He had severe ID (IQ< 30). The youngest brother
II:3 also had severe ID (IQ < 30). He had a round face with down-
slanting palpebral fissures. He had rest edema on both hands and
feet, a simian crease as well as tapering fingers. He had very small
nails on his feet. At 3 years and 5 months of age his parameters
were: height 97 cm (p50), weight 16.4 kg (p75) and OFC 51.5 cm
(p75).
3.2. Chromosome X exome sequencing
Massively parallel sequencingof all X-chromosome specific exons
of the index patient II:2 (see Fig. 1) followed by filtering of the vari-
ants against frequent variants in publicly available databases,
including the 1000 Genomes project database and dbSNP135
revealedfivemissensemutations: chrX:53581342-53581342G>A in
HUWE1, chrX:90577555-90577555T>C inPABPC5, chrX:100799179-
100799179 C>A in ARMCX2, chrX:103181324-103181324 G>A in
H2BFM and chrX:153196840-153196840 C>T in TKTL1 (all based on
UCSC genome browser build March 2006, hg18).years (d) II:3 at age 3 years. Lower panel: hands of (e) II:1 (f) II:2 and (g) II:3.
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#300407) were confirmed with Sanger sequencing. Segregation
analysis showed a similar pattern for both the HUWE1 (p.R4013W)
as well as the PABPC5 (p.I108T) substitutions, namely that the
brothers II:2 and II:3 carried both mutations, while II:1 did not.
Mother was also carrier of both mutations and her X-inactivation
status was random (61/39). A healthy sister of the mother did not
carry the mutation and other family members were not available.
In contrast to PABPC5, HUWE1 is an established XLID gene and
the same missense mutation has been reported before by Froyen
et al. [13]. Therefore, we classified the HUWE1 mutation as the
pathological mutation in this family. Considering limited informa-
tion on and low expression levels of PABPC5 in brain and other
tissues, pathogenicity of this variant is less likely, though a modi-
fying effect on the phenotype cannot be ruled out.
4. Discussion
In this study we describe the presence of a HUWE1 missense
mutation discovered by chromosome X exome sequencing in a
family with idiopathic intellectual disability. Segregation analysis
based on the sheer presence or absence of ID could have provided a
pitfall in diagnosis, since there was an intrafamilial difference in
severity of the phenotype. We demonstrate that the HUWE1 mu-
tation segregates with the severe phenotype in some individuals
from this family and therefore provides an explanation for this
diversity.
Patients with a duplication involving HUWE1 are usually
described to have a nonsyndromic mild to moderate ID [13,15]. Few
affected individuals are reported to have minor dysmorphic fea-
tures, but a consistent pattern among all duplication carriers is
lacking. So far, three HUWE1 missense mutations have been re-
ported [13]. All cases presented with nonsyndromic moderate to
profound ID. Macrocephaly was present in one of the families in
affected individuals as well as carrier females. Carrier females of
this family also had learning difficulties [16]. Recently, a fourth
HUWE1 missense mutation has been reported in a screening of
patients with autism spectrum disorders [12]. This rare
p.Val950Asp variant occurred de novo and is expected to be
involved in the phenotype.
HUWE1 encodes an E3 ubiquitin ligase, which is involved in
cancer as well as neuronal development. D’Arca et al. and Zhao et al.
demonstrated an essential role of HUWE1 in development of the
cerebellum and neurogenesis by studying targeted Huwe1 inacti-
vation in the mouse brain [17,18].
The p.R4013Wmutation found in this family has been described
previously in an Australian family [13,16]. Interestingly, macro-
cephalywas found in all affectedmembers of this family, in contrast
to the unaffected family members. Although relative macrocephaly
is also present in our study in brothers II:1 and II:2, II:1 did not
carry the mutation. Patient II:3 did carry the mutation, but had no
macrocephaly. This argues that macrocephaly, although present in
the majority of affected patients, is not a consistent feature. It has
also not been found in two other families with different HUWE1
mutations [13]. The features that the two affected male mutation
carriers in this family have in common e in contrast to their non-
carrier brother e are: more severe ID, downslanting palpebral fis-
sures, tapering fingers and rest edema on both hands and feet. The
presence of tapering fingers has also been described in one of the
affected individuals by Turner et al. (Patient III:14) [16].
It remains difficult to estimate the influence of the HUWE1
mutation in the mother. Her random X-inactivation status might
support certain effect of the mutation on her cognitive function.
The cognitive limitations of brother II:1 can most likely be
explained by a multifactorial model, including genes with modifiereffects: de novo or inherited from one or both parents. Exome
sequencing of this patient alongwith the parents could help further
explore this hypothesis, although the yield of such a study is
questionable.
HUWE1 is a dosage-sensitive gene and copy number variations
of this gene have recurrently been linked to ID [13,15]. Here, we
would like to emphasize the importance of pathological point
mutations in the gene. The absence of truncating mutations of
HUWE1 might be explained by prenatal male lethality, similar to
the absence of HUWE1 deletion reports. The combination of XLID,
downslanting palpebral fissures and tapering fingers with or
without macrocephaly might be recurrent features of the HUWE1
ID phenotype, though this will need to be confirmed by additional
patient reports.
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